Dr. Reddy's
RDY
$70.91
Share price
-0.56%
Change (1 day)
17.52%
Change (1 year)
Categories
Dr. Reddy's (RDY) - Cash on Hand
Cash on Hand as of December 2023 : $0.86 B
According to Dr. Reddy's's latest financial reports the company has $0.86 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Dr. Reddy's - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-03-31 | $0.75 B | 28.65% |
| 2022-03-31 | $0.58 B | 24.29% |
| 2021-03-31 | $0.47 B | 37.89% |
| 2020-03-31 | $0.34 B | -4.26% |
| 2019-03-31 | $0.35 B | 10.72% |
| 2018-03-31 | $0.32 B | 15.06% |
| 2017-03-31 | $0.27 B | -53.5% |
| 2016-03-31 | $0.60 B | -5.1% |
| 2015-03-31 | $0.63 B | 13.2% |
| 2014-03-31 | $0.56 B | 37.64% |
| 2013-03-31 | $0.40 B | 14.1% |
| 2012-03-31 | $0.35 B | 176.27% |
| 2011-03-31 | $0.12 B | -43.18% |
| 2010-03-31 | $0.22 B | 88.45% |
| 2009-03-31 | $0.12 B | -60.48% |
| 2008-03-31 | $0.30 B | -26.96% |
| 2007-03-31 | $0.41 B | 397.87% |
| 2006-03-31 | $83.92 M | -61.87% |
| 2005-03-31 | $0.22 B | 37.68% |
| 2004-03-31 | $0.15 B | 83.82% |
| 2003-03-31 | $86.96 M | 42.1% |
| 2002-03-31 | $61.2 M | 969.44% |
| 2001-03-31 | $5.72 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $13.96 B | 1,506.36% | 🇨🇭 Switzerland |
 Pfizer PFE | $12.69 B | 1,360.02% | 🇺🇸 USA |
 Sanofi SNY | $9.92 B | 1,042.26% | 🇫🇷 France |
 GlaxoSmithKline GSK | $6.35 B | 631.14% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $3.22 B | 271.16% | 🇮🇱 Israel |